Abbreviations
The following abbreviations are used throughout the text of the ESI file: Abs, absorption; ATR, attenuated total reflectance; CH 3 CN, acetonitrile; CH 3 OH, methanol; DCM, dichloromethane; DMF, N,N-dimethylformamide; DMSO, dimethylsulfoxide; equiv., equivalent(s); Em, emission; EtOAc, ethyl acetate; EtOH, ethanol; ESI, electrospray ionisation; Ex, excitation; FA, formic acid; HPLC, high-pressure liquid chromatography; IR, infrared; LAP, leucyl-aminopeptidase; LRMS, low-resolution mass spectrum; min, minutes; NaHCO 3 , sodium hydrogenocarbonate; NaOAc, sodium acetate; (NH 4 ) 2 SO 4 , ammonium sulfate; NMR, nuclear magnetic resonance; PB, phosphate buffer; PBS, phosphate buffered saline; PGA, penicillin G acylase; MgCl 2 , magnesium chloride; MS, mass spectrometry; RP, reversed phase; rpm, revolution per minute; RT, room temperature; t R , retention time; UV, ultraviolet; vis, visible. Phosphorous oxychloride (POCl 3 ) (7.0 mL, 72.6 mmol, 3 equiv.) was added dropwise to dry DMF (9.5 ml, 121 mmol, 5 equiv.) at 0 °C. Then 3-(N,N-diethylamino)phenol (4.0 g, 24.2 mmol, 1 equiv.) in dry DMF (15 mL) was slowly added to the previous mixture and the resulting solution was heated at 75 °C for 2 h 30 and at RT overnight. Thereafter, the reaction mixture was cooled to RT, poured into ice cold water and neutralized with aq. saturated NaHCO 3 and then the solid was collected by filtration. The solid was retaken with DCM and filtrated over a plug of silica gel, eluted with DCM/EtOAc (9 : 1, v/v). The filtrate was evaporated under vaccum and the product 1 was cristalised in EtOH/ water (9 : 1, v/v) to afford 1 as white solid (3.9 g, yield 83%). IR (ATR): n = 3374 (broad), 2974, 1624, 1558, 1517, 1490, 1446, 1414, 1378, 1335, 1303, 1236, 1217, 1186, 1125, 1096, 1077, 1012, 958, 869, 841, 802, 772 
Fluorescence assays:
All assay were performed at 37 °C (using a Peltier temperature controler and water circulation, and conducted with magnetic stirring, rpm = 300). For both probes 4 and 5, the fluorescence emission of the release 6-N,N-diethylamino-3H-xanthen-3-imine was monitored at l = 545 nm (bandwidth = 5 nm) (Ex. l = 525 nm, bandwidth = 5 nm) over time with measurements recorded every 5 s.
Protocol:
Probe 4 -Into a 3.5 mL fluorescence quartz cell, 1.2 µL of mixture A was diluted in 3 mL of selected aq. buffer (final concentration of probe: 1 µM) with additive (none or 2 µL of E or 6 µL of F or both) and the resulting mixture was incubated for 5 min. Then 1.2 µL of enzyme solution (mixture C, 1 U) was added.
Probe 5 -Into a 3.5 mL fluorescence quartz cell, 2 µL of mixture B was diluted in 3 mL of selected aq. buffer (final concentration of probe: 1 µM) and the resulting mixture was incubated for 5 min. Then, 2 µL of enzyme solution (mixture D, 0.002 U) was added.
Protocol for negative controls: Probe 4 -Into a 3.5 mL fluorescence quartz cell, 1.2 µL of mixture A was diluted in 3 mL of PB (100 mM, pH 7.6) and the resulting mixture was incubated for 5 min. Then 2 µL of LAP solution (mixture D, 0.002 U) was added.
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Probe 5 -Into a 3.5 mL fluorescence quartz cell, 2 µL of mixture B was diluted in 3 mL of selected PB (100 mM, pH 7.6) and the resulting mixture was incubated for 5 min. Then, 1.2 µL of PGA solution (mixture C, 1 U) was added.
HPLC-fluorescence analyses:
Enzymatic reaction mixtures from fluorescence assays were directly analysed by RP-HPLC-fluorescence after an incubation time of 24 h (injected volume: 10 µL, system H).
HPLC-MS analyses (enzyme assay and sample treatment):
Incubation protocols: Probe 4 -39 nmol (16 µL of mixture A) fluorogenic PGA-sensitive probe was dissolved in selected aq. buffer (470 µL) containing 1.2 µL of PGA solution (mixture C, 1 U) and the resulting enzymatic reaction mixture was incubated at 37 °C for 24 h. Probe 5 -39 nmol (27 µL of mixture B) fluorogenic LAP-sensitive probe was dissolved in selected aq. buffer (420 µL) containing 50 µL of LAP solution (mixture D, 0.05 U) and the resulting enzymatic reaction mixture was incubated at 37 °C for 24 h. Samples (50 µL) were taken at 30 min, 2 h, 5 h, 8 h and 24 h of reaction and were treated as described below.
Samples treatment for HPLC-MS analysis:
Withdrawn sample (50 µL) was diluted with 50 µL of CH 3 CN, then vortexed followed by centrifugation (9 000 rpm, 2 min) and finally, 75 µL of the supernatant was collected and diluted with 25 µL of ultrapure H 2 O. 15 µL was injected into the HPLC-MS apparatus (system G).
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ESI+ / ESI-mass spectra (low resolution) and UV-vis spectrum of compound 1 Fluorescence emission at 545 nm (AFU)
RP-HPLC elution profile of compound 1 (system A, detection at 260 nm)

Time (s)
Probe 5 in PB pH 7.6
Probe 5 in NaOAc buffer pH 5.6
Probe 5 in borate buffer pH 8.6
Probe 5 + (NH4)2SO4 + MgCl2 in PB pH 7.6
Probe 5 + LAP in PB pH 7. 6   0   50   100   475  490  505  520  535  550  565  580  595  610  625  640 Normalized intensity
Wavelength (nm)
Probe 5 + LAP in PB pH 7.6 after 24 h Pyronin 6 at the same concentration in PB Probe 5 + LAP in NaOAc buffer pH 5.6
Probe 5 in NaOAc buffer pH 5.6 (before kinetics) 
S27
